A new device for weight loss — a swallowable gastric balloon that requires no invasive procedures — may soon be approved by the U.S. Food and Drug Administration (FDA) after a nationwide clinical trial that is being overseen by Shelby Sullivan, MD, professor of gastroenterology at the University of Colorado School of Medicine and director of the Metabolic and Bariatric Program.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045